Dr. Chan Sau Yan Thomas - Haematology & Haematological Oncology
Specialist in Haematology & Haematological Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Haematology & Haematological OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Physicians · Medical degree 2006
- InsuranceBeing compiled｜See details
About
Dr. Chan Sau Yan Thomas is a registered Haematology & Haematological Oncology specialist in Hong Kong.
Education
Specialist in Haematology & Haematological Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2006
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Chan Sau Yan Thomas? Claim page and update insurance →
FAQ
Is Dr. Chan Sau Yan Thomas any good?
Dr. Chan Sau Yan Thomas is a registered Haematology & Haematological Oncology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Chan Sau Yan Thomas do?
Dr. Chan Sau Yan Thomas practises in Haematology & Haematological Oncology.
Are you Dr. Chan Sau Yan Thomas? Claim this page to update and manage.
ClaimResearch and publications
15 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.Experimental hematology & oncology · 2023
- Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy.Virology journal · 2023
- Supportive care and symptom management in patients with advanced hematological malignancies: a literature review.Annals of palliative medicine · 2022
- Early integrated palliative care for haematology cancer patients-the impact on symptom burden in Hong Kong.Annals of palliative medicine · 2021
- Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.Leukemia · 2021
- Impact of enhanced haematology palliative care services in patients with myelodysplastic syndrome and acute myeloid leukaemia: study protocol for a randomized controlled trial.Annals of palliative medicine · 2021
- Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.Leukemia · 2020
- Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong.Journal of medical economics · 2020
- Risk assessment of venous thromboembolism in hematological cancer patients: a review.Expert review of hematology · 2020
- Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBV.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2019
- Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.Hepatology (Baltimore, Md.) · 2017
- Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.Oncotarget · 2017
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer